LUMINEX CORP·4

Jul 17, 10:52 AM ET

Collins Charles J. 4

4 · LUMINEX CORP · Filed Jul 17, 2020

Insider Transaction Report

Form 4
Period: 2020-07-15
Collins Charles J.
SR VP, R&D - US
Transactions
  • Sale

    Common Stock

    2020-07-15$34.50/sh37,252$1,285,29834,554 total
  • Exercise/Conversion

    Common Stock

    2020-07-15$15.93/sh+37,252$593,42471,462 total
  • Exercise/Conversion

    Stock Option (Right To Buy)

    2020-07-15$15.93/sh37,252$593,4240 total
    Exercise: $15.93From: 2017-03-11Exp: 2022-03-11Common Stock (37,252 underlying)
Footnotes (2)
  • [F1]This sale is being made pursuant to a trading plan intended to comply with Rule 10b5-1 adopted by the seller on May 28, 2020. The representation regarding the seller's knowledge of material adverse non-public information speaks as of the date that the aforementioned trading plan was adopted.
  • [F2]This balance includes 344 shares obtained under the Luminex Corporation Employee Stock Purchase Plan on May 29, 2020.

Documents

1 file
  • 4
    wf-form4_159499752495546.xmlPrimary

    FORM 4